185 related articles for article (PubMed ID: 19717381)
1. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.
Kelly JL; Toothaker SR; Ciminello L; Hoelzer D; Holte H; LaCasce AS; Mead G; Thomas D; Van Imhoff GW; Kahl BS; Cheson BD; Magrath IT; Fisher RI; Friedberg JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):307-10. PubMed ID: 19717381
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Burkitt lymphoma in children and adults: Lessons from Africa.
Magrath IT
Curr Hematol Malig Rep; 2006 Dec; 1(4):230-40. PubMed ID: 20425318
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
Roschewski M; Dunleavy K; Abramson JS; Powell BL; Link BK; Patel P; Bierman PJ; Jagadeesh D; Mitsuyasu RT; Peace D; Watson PR; Hanna WT; Melani C; Lucas AN; Steinberg SM; Pittaluga S; Jaffe ES; Friedberg JW; Kahl BS; Little RF; Bartlett NL; Fanale MA; Noy A; Wilson WH
J Clin Oncol; 2020 Aug; 38(22):2519-2529. PubMed ID: 32453640
[TBL] [Abstract][Full Text] [Related]
5. [Burkitt lymphoma, a diagnostic emergency].
Bredin S; Vergé V; Ribrag V
Rev Prat; 2016 Jan; 66(1):79-82. PubMed ID: 30512408
[TBL] [Abstract][Full Text] [Related]
6. Adult Burkitt lymphoma: advances in diagnosis and treatment.
Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO
Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Wästerlid T; Brown PN; Hagberg O; Hagberg H; Pedersen LM; D'Amore F; Jerkeman M
Ann Oncol; 2013 Jul; 24(7):1879-1886. PubMed ID: 23446093
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
9. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Oosten LEM; Chamuleau MED; Thielen FW; de Wreede LC; Siemes C; Doorduijn JK; Smeekes OS; Kersten MJ; Hardi L; Baars JW; Demandt AMP; Stevens WBC; Nijland M; van Imhoff GW; Brouwer R; Uyl-de Groot CA; Kluin PM; de Jong D; Veelken H
Ann Hematol; 2018 Feb; 97(2):255-266. PubMed ID: 29209924
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Cortes J; Thomas D; Rios A; Koller C; O'Brien S; Jeha S; Faderl S; Kantarjian H
Cancer; 2002 Mar; 94(5):1492-9. PubMed ID: 11920506
[TBL] [Abstract][Full Text] [Related]
11. How I treat Burkitt lymphoma in adults.
Jacobson C; LaCasce A
Blood; 2014 Nov; 124(19):2913-20. PubMed ID: 25258344
[TBL] [Abstract][Full Text] [Related]
12. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
[TBL] [Abstract][Full Text] [Related]
13. Adult Burkitt lymphoma: too soon to declare victory.
Cheson BD
Oncology (Williston Park); 2008 Nov; 22(13):1518-9. PubMed ID: 19227573
[No Abstract] [Full Text] [Related]
14. [Intensive chemotherapy for Burkitt lymphoma in HIV positive patients].
Puga L B; Bustamante K K; Molina E J; Andrade M A
Rev Med Chil; 2015 Dec; 143(12):1505-11. PubMed ID: 26928610
[TBL] [Abstract][Full Text] [Related]
15. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Fayad L; Thomas D; Romaguera J
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.
Vasseur L; Prevot S; Mounier N; Costagliola D; Besson C
Eur J Cancer; 2020 Oct; 138():189-192. PubMed ID: 32896718
[No Abstract] [Full Text] [Related]
17. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
[TBL] [Abstract][Full Text] [Related]
18. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
Cairo MS; Sposto R; Perkins SL; Meadows AT; Hoover-Regan ML; Anderson JR; Siegel SE; Lones MA; Tedeschi-Blok N; Kadin ME; Kjeldsberg CR; Wilson JF; Sanger W; Morris E; Krailo MD; Finlay JL
Br J Haematol; 2003 Feb; 120(4):660-70. PubMed ID: 12588354
[TBL] [Abstract][Full Text] [Related]
19. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
[TBL] [Abstract][Full Text] [Related]
20. R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Chamuleau MED; Stenner F; Chitu DA; Novak U; Minnema MC; Geerts P; Stevens WBC; Zenz T; van Imhoff GW; Wu KL; Demandt AMP; Kersten MJ; Terpstra WE; Tick LW; Deeren D; Van Den Neste E; Gregor M; Veelken H; Böhmer LH; Caspar CB; Mutsaers P; Refos JM; Sewsaran R; Fu L; Seefat RL; Uyl-de Groot CA; Dirnhofer S; Van Den Brand M; de Jong D; Nijland M; Lugtenburg P
Lancet Haematol; 2023 Dec; 10(12):e966-e975. PubMed ID: 37922925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
